Osteopathy Treatment for Cancer Pain Related to the Confinement to Bed
Not Applicable
Completed
- Conditions
- Cancer Patient Confined in the Bed
- Interventions
- Other: Osteopathic treatment
- Registration Number
- NCT03440957
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
Staying confined in the bed is frequent at the end of life. The cancer patients can also experiment this situation, and consequences are painful, with pain increasing with the time. This pain are related to the joints stiffing , muscles mass decreasing, and tendons retractions . The non pharmacological approach associated with the conventional treatments can be interesting to assess in this frails patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
- Man or woman
- Aged 18 years or older
- Having signed informed consent to participate in the study
- Patient affiliated to a social security scheme
- Patient with pain affecting the musculoskeletal system following prolonged bed rest
- Capable to understand French
- Capable of completing self-assessment scales
Read More
Exclusion Criteria
- Patients with bone metastases at risk for the use of osteopathy
- Patients under legal protection measures
- Patients with cognitive impairment preventing self-evaluation
- Patient who is considered too fragile or with a clinical condition too unstable by the doctor refer to be included in the study
- Patients in the pre-agonic or agonic phase
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Osteopathy treatment Osteopathic treatment -
- Primary Outcome Measures
Name Time Method Decreased pain intensity of 2 points measured by Analog Visual Scale (AVS) before and after the session 15 days
- Secondary Outcome Measures
Name Time Method Decrease in analgesic consumption for pain related to immobilization 15 days Decreased 2 points of intensity of other symptoms associated before and after session measured with Edmonton Symptom Assessment System (ESAS). 15 days
Trial Locations
- Locations (1)
Hôpital Lyon Sud
🇫🇷Pierre-Bénite, France